All In Biotech

Drug Trial Radar · NCT06075706

Trial of Efficacy and Safety of MC0518 Versus Best Available Therapy in Participants With Steroid-Refractory Acute Graft Versus Host Disease

A Randomised, Open-label, Controlled, Multicentre, Phase 2 Trial of First-line Treatment With Mesenchymal Stromal Cells MC0518 Versus Best Available Therapy in Paediatric Participants With Steroid-refractory Acute Graft-versus-host Disease After Allogeneic Stem Cell Transplantation (BALDER Trial)

Last checked: Nov 19, 2026Latest source record: Apr 14, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Active, not recruiting

Status

Active, not recruiting

Enrollment

49

Actual

Start

Nov 13, 2023

Primary completion

Feb 11, 2026

Study completion Jun 2031

Sponsor

Lead sponsor
medac GmbHIndustry
Sponsor type
Industry
First posted
Oct 10, 2023

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
All sexes, from 28 days, up to 17 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this trial is the comparative evaluation of overall response rate (ORR) in paediatric participants with steroid-refractory acute graft-versus-host disease (SR-aGvHD) at Visit Day 28 after treatment with MC0518 or first used best available therapy (BAT).

Conditions

  • Steroid-refractory Acute Graft-versus-host Disease

Interventions

  • MC0518Biological

    MC0518 will be intravenously infused immediately after thawing.

  • BATBiological

    BAT including ECP, ATG, etanercept, infliximab or RUX will be administered based on Investigator's decision.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Number of Participants With Overall Response (OR)Time frame: At Day 28

Locations

36 sites in 5 countries. Site status is shown where the registry gives one.

  • CHU de Bordeaux - Hopital des Enfants

    Bordeaux, France

  • CHU Grenoble Alpes - Hopital Couple Enfant (HCE)

    La Tronche, France

  • Centre Hospitalier Universitaire de Lille CHU Lille - Hopital Jeanne de Flandre HJF

    Lille, France

  • Institut d'Hematologie et d'Oncologie Pediatrique (IHOPe)

    Lyon, France

  • CHU de Marseille-Hopital de la Timone

    Marseille, France

  • Centre Hospitalier Regional Universitaire (CHRU) Montpellier - hopital Arnaud de Villeneuve

    Montpellier, France

  • CHU de Nantes - Hopital Mere Enfant

    Nantes, France

  • Hopital Robert Debre

    Paris, France

  • CHU de Rouen - Hopital Charles Nicolle

    Rouen, France

  • CHRU de Strasbourg - Hopital de Hautepierre

    Strasbourg, France

  • CHRU Nancy, Hopitaux de Brabois

    Vandœuvre-lès-Nancy, France

  • Uniklinik RWTH Aachen, Klinik fur Kinder- und Jugendmedizin

    Aachen, Germany

  • Universitaetsklinikum Essen

    Essen, Germany

  • Klinikum der Johann Wolfgang Goethe

    Frankfurt, Germany

  • Universitaetsklinikum Freiburg - Zentrum fuer Kinder- und Jugendmedizin (ZKJ)

    Freiburg im Breisgau, Germany

  • Justus-Liebig-Universitaet Giessen

    Giessen, Germany

  • Medizinische Hochschule Hannover MHH

    Hanover, Germany

  • Department of Pediatrics, Jena University Hospital

    Jena, Germany

  • Universitaetsklinikum Leipzig - Abteilung fuer Paediatrische Onkologie, Haematologie und Haemostaseologie

    Leipzig, Germany

  • Universitaetsklinikum Muenster (UKM) - Klinik fuer Kinder- und Jugendmedizin - Paediatrische Haematologie und Onkologie

    Münster, Germany

  • IRCCS Azienda Ospedaliero-Universitaria di Bologna Policlinico S.Orsola Malpighi

    Bologna, Italy

  • Pediatric Clinic Onco Hematology San Gerardo Hospital

    Monza, Italy

  • U.O.C. Oncoematologia Pediatrica, Fondazione IRCCS Policlinico San Matteo

    Pavia, Italy

  • Hematology and Cellular Therapy Ospedale Bambino Gesu

    Rome, Italy

  • A.O.U. Citta della Salute e della Scienza di Torino Ospedale Infantile Regina Margherita

    Turin, Italy

  • Dzieciecy Szpital Kliniczny im. A.Gebali w Lublinie

    Lublin, Poland

  • Szpital Kliniczny im. Karola Jonschera UM

    Poznan, Poland

  • Department of Pediatric Hematology, Oncology and BMT, Wroclaw Medical University

    Wroclaw, Lower Silesian Voivodeship, Poland

  • Hospital Universitario Vall dHebron

    Barcelona, Spain

  • Hospital Sant Joan de Deu Barcelona (HSJDB)

    Barcelona, Spain

  • Hospital Infantil Universitario La Paz

    Madrid, Spain

  • Instituto de Investigacion Biomedica de Malaga IBIMA - sede Hospital Regional Universitario de Malaga HRUM Hospital Carlos Haya

    Málaga, Spain

  • Instituto Murciano de Investigacion Biosanitaria (IMIB) Virgen de la Arrixaca

    Murcia, Spain

  • Hospital Universitari I politecnic La Fe Jose

    Valencia, Spain

  • Hospital Niño Jesus

    Madrid, Madrid, Spain

  • Clinica Universitaria de Navarra

    Pamplona, Navarre, Spain

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.